US2008132708A1PendingUtilityA1

Imidazolidine-based metal carbene metathesis catalysts

Assignee: CALIFORNIA INST OF TECHNPriority: May 24, 1999Filed: Jan 18, 2008Published: Jun 5, 2008
Est. expiryMay 24, 2019(expired)· nominal 20-yr term from priority
B01J 31/2278B01J 2531/825B01J 2531/821B01J 2231/543B01J 31/2295C07F 15/0046C08G 61/08B01J 31/2273
59
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The present invention relates to novel metathesis catalysts with an imidazolidine-based ligand and to methods for making and using the same. The inventive catalysts are of the formula wherein: M is ruthenium or osmium; X and X 1 are each independently an anionic ligand; L is a neutral electron donor ligand; and, R, R 1 , R 6 , R 7 , R 8 , and R 9 are each independently hydrogen or a substituent selected from the group consisting of C 1 -C 20 alkyl, C 2 -C 20 alkenyl, C 2 -C 20 alkynyl, aryl, C 1 -C 20 carboxylate, C 1 -C 20 alkoxy, C 2 -C 20 alkenyloxy, C 2 -C 20 alkynyloxy, aryloxy, C 2 -C 20 alkoxycarbonyl, C 1 -C 20 alkylthiol, aryl thiol, C 1 -C 20 alkylsulfonyl and C 1 -C 20 alkylsulfinyl, the substituent optionally substituted with one or more moieties selected from the group consisting of C 1 -C 10 alkyl, C 1 -C 10 alkoxy, aryl, and a functional group selected from the group consisting of hydroxyl, thiol, thioether, ketone, aldehyde, ester, ether, amine, imine, amide, nitro, carboxylic acid, disulfide, carbonate, isocyanate, carbodiimide, carboalkoxy, carbamate, and halogen. The inclusion of an imidazolidine ligand to the previously described ruthenium or osmium catalysts has been found to dramatically improve the properties of these complexes. The inventive catalysts maintains the functional group tolerance of previously described ruthenium complexes while having enhanced metathesis activity that compares favorably to prior art tungsten and molybdenum systems.

Claims

exact text as granted — not AI-modified
1 - 64 . (canceled) 
     
     
         65 . A composition of matter having the formula: 
       
         
           
           
               
               
           
         
       
       where:
 M is Ru or Os; 
 X and X 1  are each independently an anionic ligand; 
 P is phosphorus; 
 R g , R h  and R i  are each independently:
 (1) a C 1-10  alkyl group, 
 (2) a C 3-10  cycloalkyl group or 
 (3) a C 5-20  aryl group; 
 
 R, R 6 , R 7 , R 8 , and R 9  are each independently:
 (1) hydrogen, 
 (2) a C 1-10  alkyl group, 
 (3) a C 2-20  alkenyl group, 
 (4) a C 2-20  alkynyl group, 
 (5) an aryl group, 
 (6) a C 1-20  carboxylate group, 
 (7) a C 1-20  alkoxy group, 
 (8) a C 2-20  alkenyloxy group, 
 (9) a C 2-20  alkynyloxy group, 
 (10) an aryloxy group, 
 (11) a C 2-20  alkoxycarbonyl group, 
 (12) a C 1-20  alkylthiol group, 
 (13) a C 1-20  alkylsulfonyl group, 
 (14) a C 1-20  alkylsulfinyl group, 
 
 where each of R, R 6 , R 7 , R 8 , and R 9  is optionally substituted with
 (a) halogen, 
 (b) a C 1-10  alkyl group, 
 (c) a C 1-10  alkoxy group, 
 (d) an aryl group 
 (e) a hydroxyl group, 
 (f) a thiol group, 
 (g) a thioester group, 
 (h) a ketone group, 
 (i) an aldehyde group, 
 (j) an ester group, 
 (k) an ether group, 
 (l) an amino group, 
 (m) an amido group, 
 (n) an imino group, 
 (o) a nitro group, 
 (p) a carboxylic acid group, 
 (q) a disulfide group, 
 (r) a carbonate group, 
 (s) an isocyanate group, 
 (t) a carbodiimide group, 
 (u) a carboalkoxy group, or 
 (v) a carbamate group.

Join the waitlist — get patent alerts

Track US2008132708A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.